Global Manufacturer Partners with Kneat for Digital Transformation
September 26, 2025 - 09:28
LIMERICK, Ireland, Sept. 25, 2025 — A prominent multinational manufacturer specializing in advanced devices and components, encompassing industrial, consumer, and MedTech sectors, has entered into a Master Services Agreement with Kneat. This collaboration aims to enhance digital transformation efforts across the Company’s enterprise and manufacturing sites.
The Company, headquartered in the United States, boasts a workforce of over 30,000 employees and operates in more than 30 countries worldwide. By partnering with Kneat, the manufacturer seeks to streamline its validation and quality processes through innovative digitization and automation solutions.
Kneat's expertise in these areas positions it as a key player in supporting the Company's commitment to operational excellence and efficiency. This agreement signifies a strategic move towards modernizing the Company's processes, ensuring that it remains competitive in an increasingly technology-driven market. The partnership is expected to yield significant improvements in productivity and compliance across the organization.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...